Senior insider sale
Chief Medical Officer at BIONTECH SE — senior position signals high conviction
$31.90M
308.33K shares
TURECI OZLEM plans to sell 308.33K shares of BIONTECH SE valued at approximately $31.90M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Stock Option Exercise
Stock Option Exercise
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/21/2022 | Stock Option Exercise Stock Option Exercise | 123.33K | — |
| Total | 123.33K | ||
Completed
Units to sell
8.58K
Market value
$930.3K
Units to sell
12.83K
Market value
$1.33M
Units to sell
31K
Market value
$3.22M
Units to sell
1.25K
Market value
$134.8K
Units to sell
8K
Market value
$827.0K
Units to sell
61.67K
Market value
$6.23M
Units to sell
27.17K
Market value
$3.05M
Units to sell
18K
Market value
$1.84M
Units to sell
6.50K
Market value
$651.5K
Units to sell
10K
Market value
$1.00M
Planned — Approximate Date
Units to sell
123.33K
Market value
$12.67M
Units
308.33K
Value
$31.90M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
11/11/2025 | 8.58K | $930.3K | — | Completed |
11/5/2025 | 12.83K | $1.33M | — | Completed |
11/4/2025 | 31K | $3.22M | — | Completed |
11/3/2025 | 1.25K | $134.8K | — | Completed |
11/3/2025 | 8K | $827.0K | — | Completed |
10/1/2025 | 61.67K | $6.23M | — | Completed |
9/5/2025 | 27.17K | $3.05M | — | Completed |
9/4/2025 | 18K | $1.84M | — | Completed |
9/3/2025 | 6.50K | $651.5K | — | Completed |
9/2/2025 | 10K | $1.00M | — | Completed |
| Planned — Approximate Date | ||||
11/28/2025 | 123.33K | $12.67M | Nasdaq Global Select | Planned |
| Total | 308.33K | $31.90M | ||